UNIVERSITY OF SOUTHERN CALIFORNIA
Examining the Role of a Novel Long Noncoding RNA, linc02454, in Resistance of Glioblastoma to Temozolomide
Examining the Role of a Novel Long Noncoding RNA, linc02454, in Resistance of Glioblastoma to Temozolomide is a funding opportunity from UNIVERSITY OF SOUTHERN CALIFORNIA, up to 189645, closing August 31, 2026.
Aug 31, 2026
(31d left)Overview
Project Summary/Abstract Glioblastoma (GBM), the most common primary brain tumor, has a 15 month patient survival due to inevitable recurrence of tumor despite standard treatment – temozolomide chemotherapy (TMZ), radiation, and surgery. It is critical to characterize and target genes modulating GBM chemoresistance.…